Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Evernow vs Ivim Health

Evernow
Graded #356

Lower grade

vs+11.299999999999997
Ivim Health
Graded #111

Higher grade

The verdict

Ivim Health takes it — 70.1/100 to 58.8/100.

Ivim Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth weight loss program with low entry-tier semaglutide pricing and a separate program fee for tirzepatide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIvim Health +41
45
86
Dose & formulationIvim Health +11
53
64
Clinical oversightEvernow +4
83
79
Labs & monitoringEvernow +1
53
52
FulfillmentEvernow +2
67
65
Contract termsEven
55
55
Evernow · left barIvim Health · right bar

The numbers

MetricEvernowIvim Health
WeighScore58.8/10070.1/100
GradeCC
Scorecard rank#356#111
SemaglutideNot disclosed$75/mo (starting dose, compounded)
TirzepatideNot disclosed$149/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Evernow

Graded #356 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s, not compounded
  • Accepts insurance for video visits (BCBS, Anthem, UnitedHealthcare, Aetna)
  • Integrates GLP-1 weight loss with menopause and HRT care
  • Flexible one-time visit or low-cost membership models

Where it loses points

  • Weight loss is one vertical alongside menopause and HRT care
  • GLP-1 medication cost depends on insurance and is not posted
  • State availability not specified on the site
Ivim Health

Graded #111 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard